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The Recording of Monophasic Action Potentials Simultaneously from both the
Epicardial and Endocardial Surfaces of Porcine Hearts
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Background: Monophasic Action Potentials (MAPs) are electrical signals that
represent the focal depolarizations and repolarizations of cardiac myocytes. The
detection of MAPs via applied catheters may aid in determining both characteristic
waveforms as well as the relative viability of the underlying cardiac tissue. For
example, such detection would be beneﬁcial in cases of atrial ﬁbrillation, where
ablative therapies are used to kill the cells triggering the arrhythmia. By recording
MAPs at the trigger site post-ablation, the success of the treatment can be assessed
immediately, and corrected if necessary. The purpose of the present study was to
collect and compare signature endocardial and epicardial MAPs from isolated swine
hearts.
Methods: Hearts from swine were re-animated using previously described Visible
Heart methodologies: each heart was functioning in a normal sinus rhythm.
Modiﬁed 7 Fr mapping catheters, with 4 ball electrodes and 2 ring electrodes each,
were placed upon the epicardial surface while another was inserted into the heart. The
catheters were arranged such that both recorded from the same approximate
anatomical location. This was veriﬁed through internal imaging with an endoscope
and an overhead camera (and in some cases ﬂuoroscopy). Endocardial and epicardial
MAPs, along with the ECG, were recorded using a multichannel recorder.
Results: MAPs were recorded from both atrial and ventricular locations on the right
side of the heart. Preliminary results show that the proﬁle of MAPs when recorded in
the right atria differ for epicardial and endocardial sites. When comparing recordings
taken in the right ventricle however, the proﬁle of epicardial and endocardial MAPs
were nearly identical.
Conclusions: In cases of atrial ﬁbrillation an ablation may be performed either
epicardially or endocardially on the myocardium: attempting to make induced le-
sions transmural. The detection of Monophasic Action Potentials using a MAPs
catheter can be used to determine the relative, acute, viability of cardiac tissue in a
speciﬁc area, which can lead to a higher rate of success for the treatment of atrial
ﬁbrillation.
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Background: MRI guided vascular intervention and follow up imaging has advan-
tages over X-ray-imaging, such as no ionizing radiation, no iodinated contrast agent
and good soft tissue contrast. The use of MRI during angioplasty and for imaging of
the vascular stents is still challenging due to the artefacts caused by the devices made
of metal (shielding of the stent lumen). To improve the imaging of the stent an MRI
enhancing stent was developed.
Methods: Self-expandable MRI enhancing stent (8 mm x 40 mm) was made of
Nitinol. The resonant circuits that were used to enhance the MRI signal were
completely integrated into the design of the device. This stent, adjusted to the 1.5T
MRI (Signa, GE, Waukesha, Wisconsin, USA) was crimped into a self-made delivery
catheter (14F) and released in a phantom box and in a vascular phantom ﬁlled with
0.9% NaCl solution under MRI guidance. GE sequences such as gradient echo and
real time were used with parameters: TR of 34 ms, TE of 2 ms and FA between 15
and 45.
Results: MRI was successfully used as guidance for the delivery of the MRI signal
enhancing stent. The delivery was repeated 3 times in a phantom box and 3 times in
the vascular phantom. The signal enhancement in the lumen of the stent was observed
each time after the complete expansion of the device.
Conclusions: The visualization of the stent lumen can be improved by using the MRI
signal enhancing stents. This technology allows to overcome artefacts of the stent and
can bring the MRI guided vascular procedures such as angioplasty and imaging of the
vascular devices one step closer.
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Background: The Multilayer Flow Modulator (MFM) (Cardiatis, Isnes, Belgium) is a
new concept in intra-arterial hemodynamic disruptive technology, and used to treat
vascular aneurysms. The aim of this study is to examine with porcine test animals
whether the MFM can successfully treat abdominal aortic aneurysms (AAA) through
intra-arterial hemodynamic modulation without substantial parent or small branch
artery compromise.B132 JACC Vol 64/11/Suppl B jMethods: The MFM was evaluated in 8 porcine test animals with AAA experi-
mentally induced by grafted venous tissue. The planned study period was 1 month,
at which point all animals were to be euthanized and explanted for ﬁnal exami-
nation of devices and vessels. The MFM delivery system underwent a separate
evaluation with planned deployment of 8 devices in 1 pig without an induced
aneurysm.
Results: In the delivery system evaluation, navigation, placement, deployment,
and withdrawal were without complication. In the evaluation of MFM perfor-
mance in induced aneurysms, angiographic follow-up at 8 days showed 3 an-
eurysms reduced in size and 1 totally excluded. Collective examination upon ﬁnal
angiography and explantation showed an overall trend of reduction in aneurysm
size. In 2 explants, the aneurysm opening was nearly occluded with thrombus and
the venous graft wall had thickened signiﬁcantly, suggesting an evolution into an
arterial type vessel wall. No intimal hyperplasia was observed in any of the
explants. The visceral arteries covered by the device remained patent, and the
device was found to be adhering to the arterial wall with endothelization clearly
visible.
Conclusions: In this in vivo study, the MFM was implanted without intra-arterial
compromise and aneurysms were stabilized over the course of the study, while
adequate blood ﬂow was preserved to collateral arteries. Further studies are needed to
assess the MFM.
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Background: Options for pediatric circulatory support are limited and highly
invasive. A novel assist device is being developed based on the current Impella
2.5 (Danvers, MA) to provide less invasive support for children with heart
failure. Limitation for placement of most devices is related to femoral vessel
size. In small children, carotid artery (CA) diameter exceeds the femoral artery.
This study was performed to determine feasibility and technique for Impella Pedi
catheter insertion via the CA of small pigs similar in size to our target human
population.
Methods: A total of 10 implants were performed. In all animals, right common
carotid artery (RCCA) cut down was performed to expose the vessel. Two
dimensional ultrasound measurements of the RCCA were obtained prior to cut
down. Two underwent direct insertion. Eight underwent insertion via chimney
graft, 4 short (5 cm) and 4 long (12 cm). All grafts were 6 mm in diameter. The
pigs were supported for 4 hrs and the device explanted with vessel repair if
possible. Activated clotting times (ACT) and plasma free hemoglobin levels
were monitored. Necropsy was performed to evaluate for device related
complications.
Results: Successful insertion occurred in all animals. Mean RCCA diameter was
3.5 mm (smallest 3.1 mm). Repair of the RCCA in both direct insertion pigs was
not possible due to vessel damage, but was successful in animals receiving
chimney grafts. Signiﬁcant bleeding occurred in 1 pig due to inability to achieve
graft hemostasis around the sheath. No damage was noted in the RCCA of those
animals receiving chimney grafts. There was no evidence of hemolysis. Renal
emboli were noted in 3 animals. No cerebral, cardiac or splenic infarcts were
noted. There was no aortic valve, mitral valve or left ventricular endomyocardial
damage.
Conclusions: Less invasive mechanisms for circulatory support are needed in the
pediatric population. Limitations for placement are primarily related to vessel size.
This study demonstrated that successful placement of the Impella Pedi catheter can be
safely accomplished in RCCAs as small as 3.1 mm with preservation of the RCCA
following device explant.
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Background: Percutaneous circulatory support devices are being used to support the
left ventricle in cases of acute hemodynamic collapse. The present study investigated
the effect of left atrial to femoral artery bypass (TandemHeart (TH)) and left ventricle
to ascending aorta (Impella (CP)) on stroke volume (SV), end diastolic volume
(EDV), end systolic pressure (ESP), and cardiac energetics including stroke work
(SW) and pressure-volume area (PVA) in a porcine model of acute myocardial
infarction (AMI) model.
Methods: In large male pigs (avg wt¼ 74kg), an AMI was created by occluding
the left circumﬂex artery for two hours followed by 30 minutes of reperfusion.
Following reperfusion, pressure volume (PV) loops were recorded as Baseline
measurements. Then, both the Impella and the TH were implanted and alterna-
tively activated. PV loops were recorded both immediately before and duringSeptember 13–17, 2014 j TCT Abstracts/New Devices and Innovation
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMsupport with each device. For each animal, over 300 data points were collected for
EDV, ESP, SV, SW, and PVA and then compared to baseline. The results are in
Table 1.
Results: The TandemHeart device reduced the stroke work by 65% (p ¼0.013),
stroke volume by 77%, (p ¼0.020), and PVA reduction of 52% (p ¼0.061)
relative to Baseline. The Impella CP reduced the stroke work by 3% (p ¼0.758),
stroke volume by 11%, (p ¼0.42), and PVA by 23% (p ¼.391) relative to
Baseline.
Conclusions: Percutaneous ventricular assist for acute for myocardial injury affords
ventricular unloading during cardiac recovery. The Tandem heart device appears to
offer an advantage over the Impella based on these preliminary data that need to be
validated clinically.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/NeTCT-454
Safety and Efﬁcacy of the Svelte Acrobat Integrated Coronary Stent System by
Radial Approach and 5 French Catheters
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Background: Direct Stenting (DS) has become a feasible and safe technique, with
potential clinical beneﬁts, but it is only performed in 30 to 60% of all PCIs. The aim of
this study is to evaluate the success of direct Svelte Acrobat Integrated Stent System
(ISS) via radial approach and 5 French Catheters. This unique system permits easy
delivery, deployment and post-dilatation of a cobaltchromium stent, designed to direct
stenting.
Methods: Patients with Coronary Artery Disease (CAD) were prospectively
enrolled at three centers in Sao Paolo, Brazil, to percutaneous Coronary Inter-
vention (PCI) with direct stenting via radial approach and 5 F catheters. The
Primary end point was the ISS success, deﬁned as direct stenting without post-
dilatation with additional balloon and ﬁnal stenosis less than 20% with TIMI III
ﬂow.
Results: Fifty patients with 55 lesions were included. Procedure success was 98%.
In two cases the device couldn’t cross the lesion and we had to predilate, so direct
stent success was 96%. Direct stenting without additional balloon post-dilatation
and residual stenosis less than 20% was sussessfull in ﬁfty lesions, so the ISS
success was 91%. The procedure length time was 21 minutes (SD¼9), the ﬂuo-
roscopy time was 437 seconds (SD¼ 280) and contrast volume used was 103 cm3
(SD¼33). Final residual stenosis, by QCA, was only 3.4% (SD¼4). Considering
the reduced need for additional catheters, there were 20% saving in procedure
costs. There were no bleeding or vascular complications. At eight months the
event-free survival was 84%.
Conclusions: Direct stenting with the Svelte Acrobat ISS is safe and efﬁcacy in
selected patients with CAD by radial approach and 5 French catheters and also
associated to potential procedure costs reduction.
TCT-455
Tongxinluo reduces infarct size by promoting endothelial adhesion junction
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Background: Structural and functional disruption of microvascular barrier
caused by ischemia/reperfusion results in uncontrolled inﬂammation and
ischemia/reperfusion injury (IRI). Hyperglycemia may aggravate myocardial IRI
since it worsens the barrier function. Whether Tongxinluo (TXL) is involved in
reperfused diabetic heart protection through protecting cardiac microvascular
endothelial cells (CMECs) is unknown. In order to conﬁrm the effect and
mechanism of TXL-mediated cardiac protection, studies in vitro and in vivo
were conducted.
Methods: HCMECs were cultured in normal (5.5mM) and high glucose (18mM) for
48 h respectively followed by glucose-oxygen-serum deprivation (GOSD) for 2 h and
reoxygenation for 2 h. TXL (800mg/ml), PPAR-a inhibitor MK886 (1mM) were
supplemented. Endothelial monolayer permeability was assessed. VE-cadherin inter-
nalization was detected by confocal microscope and western blotting. ICAM-1
expression was detected by western blotting. ZDF rats with Type 2 diabetes mellitus
(T2DM) underwent 45 min ligation and 3 h reperfusion of LAD. Vascular perme-
ability and infarct size were determined by FITC-dextran and TTC staining
respectively.
Results: Endothelial monolayer permeability was signiﬁcantly increased after the
GOSD/ reoxygenation treatment in a time and glucose concentration-dependent
manner. Compared with the control group, TXL dramatically decreased the ﬂuores-
cence intensity (1925138 vs. 3558133) and ICAM-1 expression, but remarkably
increased the membrane/total VE-cadherin [(354)% vs. (846)%] in HCMECs.
TXL signiﬁcantly reduced ﬂuorescence intensity (2914388 vs. 4728483) and
infarct size [(456)% vs. (523)%] of ZDF rats with T2DM in AMI/reperfusion
model compared with control group. These protective effects of TXL were partly
inhibited by MK886.
Conclusions: Accordingly, TXL protects reperfused diabetic heart through
attenuating VE-cadherin-mediated paracellular hyperpermeability via PPAR-a
pathway.w Devices and Innovation B133
